Jazz Pharmaceuticals PLC Investor Update at World Sleep Congress Transcript
Welcome to the Jazz Pharmaceuticals plc Investor Update Conference Call. (Operator Instructions)
I will now turn the call over to Kathee Littrell, Head of Investor Relations at Jazz Pharmaceuticals.
Thank you, Latif, and I want to thank you all for joining us for our investor update from the World Sleep Congress.
Before we begin the webcast, I will point out that we will be making forward-looking statements today, including statements regarding our study results, plans and expectations and other business updates for JZP-258 and Sunosi.
Our forward-looking statements are subject to risks and uncertainties described in our quarterly report on Form 10-Q for the quarter ended June 30, 2019, and our other filings with the Securities and Exchange Commission and actual events and results may differ materially. We understand no -- we undertake no duty or obligation to update any forward-looking statements we make today.
Finally, I'll remind you that we are not confirming
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |